Emergent BioSolutions (EBS) Fails to deliver data

Key failure to deliver metrics for Emergent BioSolutions :

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: €0.18 M
• Last 3 months FTD volume: €1.14 M
• Last year FTD volume: €1.14 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Emergent BioSolutions (EBS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Emergent BioSolutions (EBS) - since 2013

Emergent BioSolutions (EBS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Merck MRK	€14.45 M	€88.44 M	🇺🇸 USA
SIGA Technologies SIGA	€0.84 M	€6.47 M	🇺🇸 USA
GlaxoSmithKline GSK	€25.89 M	€55.2 M	🇬🇧 UK
Celldex Therapeutics CLDX	€1.27 M	€6.71 M	🇺🇸 USA
Pfizer PFE	€50.21 M	€0.38 B	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	€9.38 M	€32.19 M	🇮🇱 Israel
Soligenix SNGX	N/A	€5.61 M	🇺🇸 USA